Homepage Post #1
MEET OUR DOCTORS
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit.
QUESTIONS? GET IN TOUCH:
News from The American Academy of Ophthalmology
- Botulinum Toxin Injections Appear to Ease Certain Manifestations of TED July 4, 2025Investigators conducted a systematic review and meta-analysis to investigate the use of botulinum toxin injections to treat upper lid retraction and strabismus in patients with thyroid eye disease (TED).
- Week in Review: Physical Activity and Visual Improvements in Glaucoma, Global AMD-Related Vision Impairment, Effect of Environmental Factors on RRD July 3, 2025Increasing physical activity may help visual outcomes in patients with glaucoma, vision impairment due to age-related macular degeneration (AMD) continues to be a problem worldwide, and weather variances may not always influence rhegmatogenous retinal detachment (RRD).
- Weekly Journal Update — July 2, 2025 July 2, 2025Persistent retinal fluid after nAMD treatment, optic disc size and cpRNFL thinning in POAG, risk of diabetic retinopathy progression after cataract surgery, neutrophil–lymphocyte ratio as a marker for orbital cellulitis, devices to treat MGD.
- The Intravitreal Dexamethasone Implant Is a Treatment Option for Uveitic Macular Edema July 1, 2025The 24-week extension of the MERIT trial reinforces the 12-week results, where better treatment efficacy for eyes with uveitic macular edema was seen with intravitreal dexamethasone implant compared with intravitreal methotrexate and ranibizumab injections.